Literature DB >> 14585685

Sulfation of silk fibroin by chlorosulfonic acid and the anticoagulant activity.

Yasushi Tamada1.   

Abstract

Silk fibroin (Bombyx mori) was sulfated using chlorosulfonic acid in pyridine. FT-IR spectra showed introduction of sulfate group by this reaction; NMR spectra indicated that sulfation occurred mainly at tyrosine and serine residues. Molecular size decreased and dispersed with sulfation. The molecular weight was estimated in around 20,000 by GPC using protein standards. Amino acid composition suggested that sulfated fibroin came from H-chain of fibroin; the crystal region of fibroin molecule remained in sulfated fibroin. The amount of sulfate groups increased with overall reaction time. The maximum amount was estimated in 1.0 mmol/g by acidimetric titration. Sulfation efficiency was calculated as 66.7%. Blood coagulation was prevented by 0.5 mg of sulfated fibroin in 1 ml of blood, while original fibroin did not show any effect. Anticoagulant activity of sulfated fibroin strongly depends on the amount of sulfate groups introduced. These results indicate that sulfate group introduction results in addition of anticoagulant function to silk fibroin. Sulfated fibroin is a new type of anticoagulant material having a protein backbone.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14585685     DOI: 10.1016/s0142-9612(03)00533-7

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  14 in total

1.  Impact of processing parameters on the haemocompatibility of Bombyx mori silk films.

Authors:  F Philipp Seib; Manfred F Maitz; Xiao Hu; Carsten Werner; David L Kaplan
Journal:  Biomaterials       Date:  2011-11-09       Impact factor: 12.479

Review 2.  Silk-based stabilization of biomacromolecules.

Authors:  Adrian B Li; Jonathan A Kluge; Nicholas A Guziewicz; Fiorenzo G Omenetto; David L Kaplan
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

Review 3.  Silk constructs for delivery of musculoskeletal therapeutics.

Authors:  Lorenz Meinel; David L Kaplan
Journal:  Adv Drug Deliv Rev       Date:  2012-04-13       Impact factor: 15.470

4.  Biomedical applications of chemically-modified silk fibroin.

Authors:  Amanda R Murphy; David L Kaplan
Journal:  J Mater Chem       Date:  2009-06-23

5.  Chemical Modification of Silk Fibroin through Serine Amino Acid Residues.

Authors:  Xiuying Liu; Qianna Xia; Jiao Zhou; Yanbo Zhang; Haiyan Ju; Zhongmin Deng
Journal:  Materials (Basel)       Date:  2022-06-22       Impact factor: 3.748

6.  Multifunctional silk-heparin biomaterials for vascular tissue engineering applications.

Authors:  F Philipp Seib; Manuela Herklotz; Kelly A Burke; Manfred F Maitz; Carsten Werner; David L Kaplan
Journal:  Biomaterials       Date:  2013-10-04       Impact factor: 12.479

7.  Modification of silk fibroin using diazonium coupling chemistry and the effects on hMSC proliferation and differentiation.

Authors:  Amanda R Murphy; Peter St John; David L Kaplan
Journal:  Biomaterials       Date:  2008-04-15       Impact factor: 12.479

8.  Production of scFv-conjugated affinity silk powder by transgenic silkworm technology.

Authors:  Mitsuru Sato; Katsura Kojima; Chisato Sakuma; Maria Murakami; Eriko Aratani; Takato Takenouchi; Yasushi Tamada; Hiroshi Kitani
Journal:  PLoS One       Date:  2012-04-04       Impact factor: 3.240

9.  Production of scFv-conjugated affinity silk film and its application to a novel enzyme-linked immunosorbent assay.

Authors:  Mitsuru Sato; Katsura Kojima; Chisato Sakuma; Maria Murakami; Yasushi Tamada; Hiroshi Kitani
Journal:  Sci Rep       Date:  2014-02-12       Impact factor: 4.379

10.  Thromboelastometric and platelet responses to silk biomaterials.

Authors:  Banani Kundu; Christoph J Schlimp; Sylvia Nürnberger; Heinz Redl; S C Kundu
Journal:  Sci Rep       Date:  2014-05-13       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.